Mountain View, CA, United States of America

Li Zhao

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations by Inventor Li Zhao

Introduction

Li Zhao is a prominent inventor based in Mountain View, CA (US). He has made significant contributions to the field of cardiovascular health, holding a total of 7 patents. His work focuses on innovative methods for delivering therapeutic agents to treat vascular diseases.

Latest Patents

One of Li Zhao's latest patents is titled "Regional delivery of therapeutic agents for the treatment of vascular diseases." This invention pertains to the targeted delivery of therapeutic agents to both afflicted and non-afflicted tissues within blood vessels. Another notable patent is "Apo A-I mimetic peptides and methods of treatment." This method involves advancing a delivery device through a blood vessel to introduce synthetic apolipoprotein A-1 (Apo A-I) mimetic peptides, which are effective in reverse cholesterol transport. Additionally, he has developed compositions that include synthetic Apo A-I mimetic peptides suitable for delivery into blood vessels.

Career Highlights

Li Zhao is currently employed at Abbott Cardiovascular Systems, Inc., where he continues to innovate in the field of cardiovascular treatments. His work has the potential to significantly improve patient outcomes in vascular health.

Collaborations

Li Zhao collaborates with notable colleagues, including Katsuyuki Murase and Irina Astafieva, who contribute to his research and development efforts.

Conclusion

Li Zhao's innovative work in the field of cardiovascular health demonstrates his commitment to advancing medical treatments through his patents and collaborations. His contributions are paving the way for new therapeutic approaches in vascular disease management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…